Carlos R Becerra Selected Research

Carlos R Becerra Research Topics

Disease

17	Neoplasms (Cancer) 01/2021 - 05/2004
3	Pancreatic Neoplasms (Pancreatic Cancer) 12/2021 - 03/2010
3	Carcinoma (Carcinomatosis) 11/2013 - 08/2005
3	Colonic Neoplasms (Colon Cancer) 10/2006 - 07/2003
2	Inflammation (Inflammations) 01/2016 - 01/2015
2	Neutropenia 02/2015 - 06/2008
2	Disease Progression 11/2014 - 10/2005
2	Colorectal Neoplasms (Colorectal Cancer) 04/2014 - 07/2003
2	Adenocarcinoma 06/2008 - 12/2004
1	Pain (Aches) 01/2016
1	Giant Cell Tumor of Tendon Sheath 01/2016
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2015
1	Esophagitis 01/2015
1	Hypokalemia 01/2015
1	Multiple Myeloma 01/2015
1	Central Serous Chorioretinopathy 01/2015
1	Head and Neck Neoplasms (Head and Neck Cancer) 11/2013
1	Esophageal Neoplasms (Esophageal Cancer) 11/2013
1	Pathologic Complete Response 11/2013
1	Sarcoma (Soft Tissue Sarcoma) 03/2010
1	Thymoma (Thymic Carcinoma) 03/2010
1	Lewis Lung Carcinoma 03/2010
1	Renal Cell Carcinoma (Grawitz Tumor) 03/2010
1	Adenocarcinoma of Lung 06/2008
1	Stomach Neoplasms (Stomach Cancer) 10/2005
1	Cholangiocarcinoma 08/2005
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 08/2005
1	Carcinogenesis 07/2005

Drug/Important Bio-Agent (IBA)

3	Irinotecan (Camptosar)FDA LinkGeneric 06/2008 - 05/2004
2	trifluridine tipiracil drug combinationIBA 01/2021 - 01/2017
2	Gemcitabine FDA Link 02/2015 - 03/2010
2	Docetaxel (Taxotere)FDA Link 02/2015 - 10/2006
2	Epirubicin (Ellence)FDA LinkGeneric 06/2008 - 12/2004
2	Capecitabine (Xeloda)FDA Link 06/2008 - 12/2004
2	Fluorouracil (Carac)FDA LinkGeneric 10/2006 - 07/2003
2	exatecan (DX 8951f)IBA 10/2005 - 08/2005
2	NF-kappa B (NF-kB)IBA 07/2005 - 05/2004
1	MicroRNAs (MicroRNA)IBA 01/2020
1	SolutionsIBA 01/2017
1	TabletsIBA 01/2017
1	Macrophage Colony-Stimulating FactorIBA 01/2016
1	AlbuminsIBA 02/2015
1	Cisplatin (Platino)FDA LinkGeneric 02/2015
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 02/2015
1	N- ((5- bromo- 2- thienyl)sulfonyl)- 2,4- dichlorobenzamideIBA 02/2015
1	SodiumIBA 02/2015
1	Temozolomide (Temodar)FDA LinkGeneric 02/2015
1	afuresertibIBA 01/2015
1	trametinibIBA 01/2015
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2015
1	Retinaldehyde (Retinal)IBA 01/2015
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2015
1	Monoclonal AntibodiesIBA 11/2014
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 11/2014
1	TovetumabIBA 11/2014
1	figitumumabIBA 04/2014
1	Cetuximab (Erbitux)FDA Link 11/2013
1	ErbB Receptors (EGF Receptor)IBA 08/2013
1	AfatinibIBA 08/2013
1	Biomarkers (Surrogate Marker)IBA 08/2013
1	human ERBB2 proteinIBA 08/2013
1	EstersIBA 03/2010
1	AcidsIBA 03/2010
1	TriterpenesIBA 03/2010
1	bardoxolone methylIBA 03/2010
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 06/2008
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 06/2008
1	AgarIBA 10/2006
1	alvocidib (flavopiridol)IBA 10/2006
1	Bevacizumab (Avastin)FDA Link 07/2006
1	Small Interfering RNA (siRNA)IBA 05/2004
1	Leucovorin (Folinic Acid)FDA Link 07/2003
1	rofecoxib (Vioxx)FDA Link 07/2003
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 07/2003
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 07/2003
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 07/2003

Therapy/Procedure

6	Drug Therapy (Chemotherapy) 01/2019 - 07/2003
5	Therapeutics 12/2021 - 10/2006
1	Radiotherapy 11/2013
1	Immunotherapy 03/2010